A new complication of chemotherapy administered via permanent indwelling central venous catheter

Bach Ardalan, M. R. Flores

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background. The use or permanent intravenous access devices for chemotherapy administration has become a common practice in clinical oncology. Therefore, awareness of potential complications is important. The authors previously reported the use of high dose 5-fluorouracil (5-FU) (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for patients with colorectal carcinoma. In this report, a new complication of permanent indwelling catheters with high dose 5-fluorouracil (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for colorectal carcinoma is described. Methods. Twenty-two patients in the previous Phase II trial on weekly high dose 5-FU and leucovorin were included in this study. All patients had either a single-lumen Port-o-cath (Pharmacia Deltec, St. Paul, MN) or Hickman catheter (Travenol Laboratories, Deerfield, IL). Occluded catheters were explanted, and the material found in their lumen was analyzed using infrared spectroscopy. Results. Eleven of 22 patients had catheter blockage, and calcium carbonate formation (Calcite 100%) was identified within these catheters. Conclusion. Calcite formation causing catheter occlusion is a new and important complication resulting from using intravenous access devices for chemotherapy administration. Oncologists should be alerted to this phenomenon when high dose 5-FU and leucovorin are administered for 24 hours by continuous infusion using a single-port port-o- cath.

Original languageEnglish
Pages (from-to)2165-2168
Number of pages4
JournalCancer
Volume75
Issue number8
DOIs
StatePublished - Apr 19 1995

Fingerprint

Indwelling Catheters
Central Venous Catheters
Leucovorin
Catheters
Fluorouracil
Calcium Carbonate
Drug Therapy
Colorectal Neoplasms
Equipment and Supplies
Medical Oncology
Spectrum Analysis

Keywords

  • catheters
  • complication
  • high dose 5-fluorouracil
  • leucovorin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A new complication of chemotherapy administered via permanent indwelling central venous catheter. / Ardalan, Bach; Flores, M. R.

In: Cancer, Vol. 75, No. 8, 19.04.1995, p. 2165-2168.

Research output: Contribution to journalArticle

@article{3cbecb2028214a20a272c4d8a886f703,
title = "A new complication of chemotherapy administered via permanent indwelling central venous catheter",
abstract = "Background. The use or permanent intravenous access devices for chemotherapy administration has become a common practice in clinical oncology. Therefore, awareness of potential complications is important. The authors previously reported the use of high dose 5-fluorouracil (5-FU) (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for patients with colorectal carcinoma. In this report, a new complication of permanent indwelling catheters with high dose 5-fluorouracil (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for colorectal carcinoma is described. Methods. Twenty-two patients in the previous Phase II trial on weekly high dose 5-FU and leucovorin were included in this study. All patients had either a single-lumen Port-o-cath (Pharmacia Deltec, St. Paul, MN) or Hickman catheter (Travenol Laboratories, Deerfield, IL). Occluded catheters were explanted, and the material found in their lumen was analyzed using infrared spectroscopy. Results. Eleven of 22 patients had catheter blockage, and calcium carbonate formation (Calcite 100{\%}) was identified within these catheters. Conclusion. Calcite formation causing catheter occlusion is a new and important complication resulting from using intravenous access devices for chemotherapy administration. Oncologists should be alerted to this phenomenon when high dose 5-FU and leucovorin are administered for 24 hours by continuous infusion using a single-port port-o- cath.",
keywords = "catheters, complication, high dose 5-fluorouracil, leucovorin",
author = "Bach Ardalan and Flores, {M. R.}",
year = "1995",
month = "4",
day = "19",
doi = "10.1002/1097-0142(19950415)75:8<2165::AID-CNCR2820750821>3.0.CO;2-W",
language = "English",
volume = "75",
pages = "2165--2168",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - A new complication of chemotherapy administered via permanent indwelling central venous catheter

AU - Ardalan, Bach

AU - Flores, M. R.

PY - 1995/4/19

Y1 - 1995/4/19

N2 - Background. The use or permanent intravenous access devices for chemotherapy administration has become a common practice in clinical oncology. Therefore, awareness of potential complications is important. The authors previously reported the use of high dose 5-fluorouracil (5-FU) (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for patients with colorectal carcinoma. In this report, a new complication of permanent indwelling catheters with high dose 5-fluorouracil (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for colorectal carcinoma is described. Methods. Twenty-two patients in the previous Phase II trial on weekly high dose 5-FU and leucovorin were included in this study. All patients had either a single-lumen Port-o-cath (Pharmacia Deltec, St. Paul, MN) or Hickman catheter (Travenol Laboratories, Deerfield, IL). Occluded catheters were explanted, and the material found in their lumen was analyzed using infrared spectroscopy. Results. Eleven of 22 patients had catheter blockage, and calcium carbonate formation (Calcite 100%) was identified within these catheters. Conclusion. Calcite formation causing catheter occlusion is a new and important complication resulting from using intravenous access devices for chemotherapy administration. Oncologists should be alerted to this phenomenon when high dose 5-FU and leucovorin are administered for 24 hours by continuous infusion using a single-port port-o- cath.

AB - Background. The use or permanent intravenous access devices for chemotherapy administration has become a common practice in clinical oncology. Therefore, awareness of potential complications is important. The authors previously reported the use of high dose 5-fluorouracil (5-FU) (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for patients with colorectal carcinoma. In this report, a new complication of permanent indwelling catheters with high dose 5-fluorouracil (2600 mg/m2) and leucovorin (500 mg/m2) as a weekly 24-hour infusion for colorectal carcinoma is described. Methods. Twenty-two patients in the previous Phase II trial on weekly high dose 5-FU and leucovorin were included in this study. All patients had either a single-lumen Port-o-cath (Pharmacia Deltec, St. Paul, MN) or Hickman catheter (Travenol Laboratories, Deerfield, IL). Occluded catheters were explanted, and the material found in their lumen was analyzed using infrared spectroscopy. Results. Eleven of 22 patients had catheter blockage, and calcium carbonate formation (Calcite 100%) was identified within these catheters. Conclusion. Calcite formation causing catheter occlusion is a new and important complication resulting from using intravenous access devices for chemotherapy administration. Oncologists should be alerted to this phenomenon when high dose 5-FU and leucovorin are administered for 24 hours by continuous infusion using a single-port port-o- cath.

KW - catheters

KW - complication

KW - high dose 5-fluorouracil

KW - leucovorin

UR - http://www.scopus.com/inward/record.url?scp=0028932540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028932540&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19950415)75:8<2165::AID-CNCR2820750821>3.0.CO;2-W

DO - 10.1002/1097-0142(19950415)75:8<2165::AID-CNCR2820750821>3.0.CO;2-W

M3 - Article

VL - 75

SP - 2165

EP - 2168

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -